Schedule 13D and 13G filings - beneficial ownership reports:

  1. Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  2. Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
  3. Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Data are delayed by 6 months. New user? Sign up for real time data. Existing user? Sign in.

SEC filing services are close in the weekend and during SEC holidays.

View:

13G Filings

2023-11-17 16:00 EST - 2023-11-20 16:00 EST


Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-11-20
3:19 pm
Purchase		13GMallinckrodt plc
MNKTQ		Flynn James E1,505,969
7.65%		1,505,969increase
(New Position)		View
2023-11-20
2:02 pm
Sale		13GPROS Holdings, Inc.
PRO		BROWN CAPITAL MANAGEMENT LLC1,940,398
4.19%		-2,821,147decrease
(-59.25%)		View
2023-11-20
1:14 pm
Sale		13GCrestwood Equity Partners LP
CEQP		CIBC Private Wealth Group LLC0
0%		-9,755,026decrease
(Position Closed)		View
2023-11-20
09:53 am
Purchase		13GArko Corp.
ARKO		Phoenix Holdings Ltd.6,233,784
5.34%		6,233,784increase
(New Position)		View
2023-11-20
09:39 am
Sale		13GIllumina, Inc.
ILMN		BAILLIE GIFFORD & CO8,608,269
5.44%		-8,134,834decrease
(-48.59%)		View
2023-11-20
08:56 am
Purchase		13GSonnet BioTherapeutics Holdings, Inc.
SONN		Ruck Matthew J11,705,996
5.2%		10,005,996increase
(+588.59%)		View
2023-11-20
08:00 am
Sale		13G2U, Inc.
TWOU		Greenvale Capital LLP3,452,353
4.2%		-1,394,811decrease
(-28.78%)		View
2023-11-17
5:15 pm
Unchanged		13GPLAYSTUDIOS, Inc.
MYPS		Activision Blizzard Inc.
ATVI		12,677,398
10.8%		0
(Unchanged)		View
2023-11-17
5:15 pm
Purchase		13GREGENXBIO Inc.
RGNX		Redmile Group LLC4,238,312
9.6%		2,341,089increase
(+123.40%)		View
2023-11-17
5:12 pm
Purchase		13GZentalis Pharmaceuticals, Inc.
ZNTL		CITADEL ADVISORS LLC3,839,829
5.4%		2,335,959increase
(+155.33%)		View
2023-11-17
4:23 pm
Sale		13GEQRx, Inc.
EQRX		ARCH Venture Fund X L.P.0
0%		-36,335,375decrease
(Position Closed)		View
2023-11-17
4:23 pm
Purchase		13GLexeo Therapeutics, Inc. Common Stock
LXEO		CITADEL ADVISORS LLC2,092,488
8.3%		2,092,488increase
(New Position)		View
2023-11-17
4:23 pm
Purchase		13GKorro Bio, Inc.
KRRO		Platanus Investment LLC540,165
6.8%		540,165increase
(New Position)		View
2023-11-17
4:21 pm
Purchase		13GAppian Corporation
APPN		CITADEL ADVISORS LLC1,957,197
4.7%		1,957,197increase
(New Position)		View
2023-11-17
4:15 pm
Sale		13GGold Reserve Inc.
GDRZF		King Theodore Walker Cheng-De0
0%		-5,335,585decrease
(Position Closed)		View
2023-11-17
4:05 pm
Purchase		13GAdvance Auto Parts, Inc.
AAP		D. E. SHAW & CO L.P.2,992,429
5%		2,992,429increase
(New Position)		View
2023-11-17
4:05 pm
Purchase		13GMaxCyte, Inc.
MXCT		INTEGRATED CORE STRATEGIES (US) LLC5,770,894
5.6%		5,770,894increase
(New Position)		View
2023-11-17
4:05 pm
Purchase		13GDestra Multi-Alternative Fund
DMA		Thomas J. Herzfeld Advisors Inc.899,421
10.03%		899,421increase
(New Position)		View
×

ERROR